Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous cation is the divalent form of iron (Fe2+), commonly used as an active ingredient in oral and parenteral iron supplements for the prevention and treatment of iron deficiency and iron-deficiency anemia. It acts by replenishing body stores of elemental iron, which is essential for hemoglobin synthesis, oxygen transport via hemoglobin in red blood cells, myoglobin function in muscles, and activity of various enzymes. The primary mechanism involves providing bioavailable elemental iron that can be incorporated into hemoglobin and other proteins requiring ferrous ions[1][5]. Ferrous cation is a human metabolite with physiological roles beyond supplementation[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous cation.